High preoperative plasma concentration of tissue plasminogen activator (tPA) is an independent marker for shorter overall survival in patients with ovarian cancer

By Borgfeldt C.   Bendahl P.-O.   Ferno M.   Casslen B.  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 112-117

Elsevier

Access to resources Recommend Favorite

Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells

By Andrews Heather   Habibi Golerah   Kucab Jill   Dunn Sandra  

Breast Cancer Research and Treatment, Vol. 94, Iss. 1, 2005-11 ,pp. : 47-52

Springer Publishing Company

Access to resources Recommend Favorite

Expression and prognostic value of plasminogen activator inhibitor type 1 in node-negative breast cancer

By Wang Bin  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 6, 2008-06 ,pp. : 339-343

Springer Publishing Company

Access to resources Recommend Favorite

Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance

By Yu Guan   Chen Ying   Wang Jie  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1331-1339

Springer Publishing Company

Access to resources Recommend Favorite

Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance

By          

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 637-645

Spandidos Publications

Access to resources Recommend Favorite